Atopic Dermatitis
Top news of October: Probiotics, COVID-19 vaccines, Epstein-Barr virus, more
Healio compiled the most-read news in allergy, asthma and immunology posted in October.
Abrocitinib demonstrates rapid efficacy in treating atopic dermatitis
A 200 mg dose of abrocitinib met stringent efficacy endpoints among substantial portions of patients with moderate to severe atopic dermatitis, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Wildfires prompt more visits to clinics for atopic dermatitis, itch among older adults
Clinics visits for itch and atopic dermatitis increased among adults aged 65 years and older during the California Camp Fire in 2018 compared with weeks without wildfire, according to a research letter published in JAMA Network Open.
Novel topical complex derived from spinach shows efficacy in atopic dermatitis
A novel investigational compound derived from baby spinach leaves yielded improvements in efficacy with an attractive safety profile in adults with atopic dermatitis, according to a study.
Healio releases Clinical Guidance, a point-of-care resource for providers
Healio has launched a new point-of-care tool with modules on medical conditions to help clinicians treat patients using reliable information.
Early emollient use reduces incidence of atopic dermatitis among high-risk infants
Infants at high risk for atopic dermatitis who used emollients daily through their first 2 months of life experienced less disease in their first year than high-risk infants who did not use emollients, according to study results.
Boy presents with ringlike lesion on his arm
A 10-year-old boy comes to your clinic with a chronic, enlarging lesion on his right arm. It began as an erythematous bump that slowly enlarged in a ringlike fashion, with a reddish color to the ring. What's your diagnosis?
Global understanding: Atopic dermatitis awareness campaign supports people around world
LEO Pharma has partnered with eczema patient advocate Ashley Ann Lora for the “AD Days Around the World” campaign, an effort to document the stories of individuals living with atopic dermatitis to help inspire others.
Acid suppressants may increase risks for asthma, allergic diseases among children
The use of acid suppressants among children may increase their risks for incident asthma, atopic dermatitis and allergic rhinitis, according to a systematic review published in The Journal of Allergy and Clinical Immunology: In Practice.
Biologics for asthma, atopic dermatitis associated with reduced COVID-19 vaccine responses
NASHVILLE, Tenn. — Patients on biologic therapies for severe asthma or atopic dermatitis had lower pseudovirus neutralization 6 months after receiving the second dose of mRNA COVID-19 vaccines, according to a study presented at CHEST 2022.